RAYMOND JAMES & ASSOCIATES - ODONATE THERAPEUTICS INC ownership

ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ODONATE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$416,000
+39.6%
9,820
-9.1%
0.00%
Q1 2020$298,000
-16.5%
10,808
-1.8%
0.00%
Q4 2019$357,000
+47.5%
11,003
+18.2%
0.00%
Q3 2019$242,0009,3050.00%
Other shareholders
ODONATE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 15,514,566$297,880,00045.48%
Boxer Capital, LLC 5,607,086$107,656,0003.46%
Samsara BioCapital, LLC 815,421$15,656,0001.57%
GSA CAPITAL PARTNERS LLP 148,148$2,844,0000.46%
DRIEHAUS CAPITAL MANAGEMENT LLC 1,211,728$23,265,0000.38%
RTW INVESTMENTS, LP 1,000,139$19,203,0000.32%
Sio Capital Management, LLC 75,500$1,450,0000.30%
AlphaCentric Advisors LLC 29,594$568,0000.24%
Birchview Capital, LP 20,000$384,0000.22%
Aristides Capital LLC 33,226$638,0000.22%
View complete list of ODONATE THERAPEUTICS INC shareholders